Lentviral and retroviral vectors are at the forefront of advanced therapeutic medicinal product (ATMP) development. The BSGCT conference in April 2018 aims to give the attendee an overview about the successes, challenges and areas for future development.
Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies.
Pick up your copy of this essential resource at the BSGCT.